History of allogeneic organ transplantation
CRITERIA FOR ALLOGENEIC TRANSPLANTATION
Prior autologous or allogeneic organ or tissue transplantation
History of allogeneic organ transplantation.
No prior history of organ transplantation or brain metastasis
History of organ transplantation including previous history of liver transplantation
Has had prior liver or other organ transplantation
History of organ transplantation
No major organ dysfunction precluding transplantation.
Patients who are candidates for allogeneic transplantation, have a suitable donor, and are willing to undergo transplantation
Anticipated liver transplantation
Prior allogeneic transplantation
Prior organ transplantation including allogeneic stem cell transplantation, brain metastases (except those meeting certain protocol specified criteria which are acceptable), significant acute or chronic infections, a history of cardiovascular/cerebrovascular disease.
Patients with autoimmune disorders or history of organ transplantation who require immunosuppressive therapy
Previous allogeneic or autologous hematopoietic cell transplantation or solid organ transplantation
Patients who have had a liver or any organ transplantation
Patients with prior orthotropic liver transplantation
History of allogeneic organ transplantation
Patients who have undergone prior liver transplantation are ineligible
PHASE I: Patients who are between T+ and T+ after allogeneic transplantation
PHASE I: Patients who have evidence of donor chimerism after allogeneic transplantation
Prior organ transplantation
History of organ transplantation
No major organ dysfunction precluding transplantation
Patients who have undergone prior liver transplantation are ineligible
Relapsed after allogeneic transplantation
History of organ transplantation
Use of any of the following after transplantation and prior to starting study therapy:
Relapsed malignancy after transplantation
History of organ transplantation
Patient diagnosed with hepatocellular carcinoma and listed for orthotopic liver transplantation at the participating institution in accordance with Organ Procurement and Transplantation Network (OPTN) guidelines
Relapsed after allogeneic transplantation
At least  days from day of transplantation
Prior autologous or allogeneic organ or tissue transplantation
Patients considered for transplantation must have a sufficient graft as based on current criteria of the University of Minnesota Blood and Marrow Transplantation Program
History of allogeneic organ transplantation
Receipt of any organ transplantation
History of allogeneic organ transplantation.
Prior autologous or allogeneic organ or tissue transplantation
No prior autologous or allogeneic organ or tissue transplantation
History of allogeneic organ transplantation.
History of organ transplantation
ALLOGENEIC TRANSPLANTATION:
History of organ transplantation
History of organ transplantation
Subjects who are candidates for allogeneic transplantation, have a suitable donor, and are willing to undergo transplantation
History of organ transplantation
Previous liver transplantation
Prior allogeneic transplantation
Patients who have undergone liver transplantation are excluded
History of major organ transplantation
History of major organ transplantation
Prior allogeneic transplantation
Subject has had or has planned to receive any organ transplantation;
Patients who have received liver transplantation
History of organ transplantation.
History of allogeneic organ transplantation;
History of allogeneic organ transplantation
Subjects who relapse after allogeneic transplantation;
Patients who have undergone prior liver transplantation are ineligible
History of organ transplantation
Patient must have no history of organ transplantation or ongoing immunosuppressant therapy
Had organ transplantation
History of any organ transplantation
Patients that underwent allogeneic transplantation as a treatment of graft failure
History of organ transplantation.
Patients that underwent allogeneic transplantation as a treatment of graft failure
History of organ transplantation
Participant who has a history of organ transplantation.
Prior organ transplantation
Prior allograft transplantation including liver transplantation.
Has received a prior allogeneic organ or tissue transplantation
The participant has received a prior autologous or allogeneic organ or tissue transplantation.
Patients who have undergone prior allogeneic transplantation are eligible provided that their transplant day  is >  months from their first dose of study drug
Transplantation of PBSC
Prior allogeneic transplantation
History of major organ transplantation with an existing functional graft
Transplantation with PBSC
Prior allogeneic transplantation
Individual with history of any organ transplantation